NCT00410943View on ClinicalTrials.gov

Study of the Effectiveness and Tolerability of OROS Hydromorphone HCI SR(Slow-release) Tablets and Immediate-Release Hydromorphone Tablets in Patients With Chronic Pain

PHASE3CompletedINTERVENTIONAL
Enrollment

169

Participants

Timeline

Start Date

Not specified

Study Completion Date

June 30, 1999

Conditions
Pain
Interventions
DRUG

OROS Hydromorphone HCI SR (slow release)

All Listed Sponsors
lead

Alza Corporation, DE, USA

INDUSTRY

NCT00410943 - Study of the Effectiveness and Tolerability of OROS Hydromorphone HCI SR(Slow-release) Tablets and Immediate-Release Hydromorphone Tablets in Patients With Chronic Pain | Biotech Hunter | Biotech Hunter